Serna J, González-Guerrero P R, Scanes C G, Prati M, Morreale G, de Pablo F
Department of Cell and Developmental Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Growth Regul. 1996 Jun;6(2):73-82.
The control of embryonic growth in vertebrates appears to rely on the orchestrated action of several families of growth factors and hormones. The contribution of insulin-like growth factor (IGF-I) to prenatal growth regulation is better established in mammals than in other vertebrate species. The status of (pro)insulin gene product(s) in the pancreas and non-pancreatic tissues may be another important contribution to embryonic growth signals. We have characterized tissue sources of IGF-I gene and (pro)insulin gene mRNAs in normal chicken embryogenesis and their changes in a model of avian growth retardation. We studied, by a highly sensitive reverse-transcription coupled to polymerase chain reaction (RT-PCR), the expression of IGF-I and (pro)insulin genes in brain, pancreas, liver and eye in embryos from late organogenesis (E8) to late development (E17); hatching is at E20-21, a period of fast embryonic growth. In brain, pancreas and eye, growth-retarded embryos had lower IGF-I mRNA expression. In contrast, in the liver, little IGF-I mRNA was found during normal embryogenesis, but some early induction occurred in E17 growth-retarded embryos. (pro)insulin gene expression was much lower in absolute levels in non-pancreatic tissues than in pancreas. However, it was developmentally regulated in brain, liver and eye. The growth-retarded, IGF-I-deficient embryos had an increased expression of (pro)insulin mRNA in the brain. While IGF-I treatment of growth-retarded embryos increased their serum IGF-I values, only partial recovery of embryonic weight was obtained. Since abnormalities in other hormones may contribute to the failure of systemic IGF-I to reverse the retarded phenotype, thyroid hormones (T3 and T4) levels were determined in liver, brain and eye. They were markedly altered only in the liver of growth-retarded embryos, where an increase in thyroid hormone content was observed. We conclude that, in chicken embryos and possibly other vertebrates, normal growth may implicate multiple hormones, including the concerted action, endocrine/paracrine, of IGF-I and (pro)insulin gene products.
脊椎动物胚胎生长的调控似乎依赖于多种生长因子和激素家族的协同作用。胰岛素样生长因子(IGF-I)对产前生长调节的作用在哺乳动物中比在其他脊椎动物物种中得到了更好的确立。胰腺和非胰腺组织中(前)胰岛素基因产物的状态可能是对胚胎生长信号的另一个重要贡献。我们已经鉴定了正常鸡胚胎发育过程中IGF-I基因和(前)胰岛素基因mRNA的组织来源,以及它们在禽类生长迟缓模型中的变化。我们通过高度敏感的逆转录聚合酶链反应(RT-PCR)研究了从器官发生后期(E8)到发育后期(E17)的胚胎脑、胰腺、肝脏和眼中IGF-I和(前)胰岛素基因的表达;孵化发生在E20-21,这是胚胎快速生长的时期。在脑、胰腺和眼中,生长迟缓的胚胎IGF-I mRNA表达较低。相反,在肝脏中,正常胚胎发育过程中几乎没有发现IGF-I mRNA,但在E17生长迟缓的胚胎中出现了一些早期诱导。非胰腺组织中(前)胰岛素基因的表达绝对水平比胰腺中低得多。然而,它在脑、肝脏和眼中受到发育调控。生长迟缓、IGF-I缺乏的胚胎脑中(前)胰岛素mRNA的表达增加。虽然用IGF-I处理生长迟缓的胚胎可提高其血清IGF-I值,但仅部分恢复了胚胎体重。由于其他激素的异常可能导致全身性IGF-I无法逆转发育迟缓的表型,因此测定了肝脏、脑和眼中的甲状腺激素(T3和T4)水平。仅在生长迟缓胚胎的肝脏中它们有明显改变,其中观察到甲状腺激素含量增加。我们得出结论,在鸡胚胎以及可能的其他脊椎动物中,正常生长可能涉及多种激素,包括IGF-I和(前)胰岛素基因产物的内分泌/旁分泌协同作用。